June 4th 2004The herbal product category has had a difficult year. First came the ephedra ban. Then came new studies questioning the efficacy of several common extracts. And in case you missed those items, there was also the article on 'dangerous supplements still at large' in the May issue of Consumer Reports.Despite the steady stream of bad news, manufacturers are optimistic that the category will survive, and even prosper, in the years ahead.